Update on Overall Survival for Newly Diagnosed Patients With Metastatic Pancreatic Cancer

LW Newsfeed
Although “treatment advances” and “precision medicine” are today’s buzz words in oncology, they don’t apply equally to all malignancies.

For instance, median overall survival for newly diagnosed patients with metastatic pancreatic cancer has not improved much over the past 20 years, according to analysis of more than 50,000 patients.1 However, more patients are achieving “long-term” survival, but it is defined as 12 months or more, and this fraction of patients is still limited to about 12%, investigators reported at the 2017 Gastrointestinal Cancers Symposium. Read more . . . 

image_printPrint Page